Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
US Department of Justice
Medtronic
Chinese Patent Office
Farmers Insurance
Cerilliant
UBS
McKesson
Federal Trade Commission

Generated: January 23, 2018

DrugPatentWatch Database Preview

CEFEPIME HYDROCHLORIDE Drug Profile

« Back to Dashboard

Drug patent expirations by year for CEFEPIME HYDROCHLORIDE
Pharmacology for CEFEPIME HYDROCHLORIDE

US Patents and Regulatory Information for CEFEPIME HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065441-001 Mar 20, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065369-001 Jun 18, 2007 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 202268-001 Jul 30, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Pharms CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 091048-002 Jan 4, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Qilu Pharm Co Ltd CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 203704-002 Feb 1, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 090291-003 Dec 21, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065441-002 Mar 20, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065369-002 Jun 18, 2007 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 202268-002 Jul 30, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065369-003 Jun 18, 2007 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Citi
Novartis
Chubb
McKesson
Colorcon
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot